Abnova Mutual Funds | StatInvestor

Health Care & Life Sciences » Biotechnology | Abnova

Abnova | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Luxcellence - Polunin Emerging Markets Technology Fund

334,757

0.55%

1.48%

06/30/2017

DFA TA World (ex-US) Core Equity Portfolio

11,000

0.02%

04/30/2018

View Profile

Address	108 Jhouzih Street Taipei TP 114 Taiwan
Employees	-
Website	http://www.abnova.com.tw
Updated	07/08/2019
Abnova Taiwan Corp. is engaged in researching, developing, manufacturing and selling antibodies. It also supplies medicines and human genes albumen. Its products include antibodies for virus, microbial, neuroscience and others.